Anti-inflammatory therapy with yellow light for rosacea
Treatments studied
Part of Skin clinical trials.
This trial tests a combination of an anti-inflammatory gel (Hirudoid), yellow light therapy, and two oral medications (tofacitinib and doxycycline) for Chinese adults with mild to moderate rosacea that causes redness and visible blood vessels. The goal is to see if this approach reduces symptoms safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have mild to moderate rosacea with redness and visible blood vessels (erythematous telangiectatic type).
- You are willing to avoid triggers like spicy food, alcohol, and too much sun during the study.
- You agree not to use other rosacea treatments during the study.
- If you could become pregnant, you agree to use effective birth control and not plan a pregnancy for 3 months after the last treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if creams containing two antidepressants (imipramine and amitriptyline) can reduce skin redness caused by UV light in people with rosacea. It compares how the creams affect redness to see if they could be a new treatment option.
This study tests a special cream to reduce facial redness caused by rosacea, either alone or combined with laser treatment. It aims to help people with persistent redness and visible blood vessels on their face.
This trial tests whether acupuncture can help people with rosacea that hasn't improved with standard treatments like oral antibiotics or light therapy. If you have persistent redness or flushing that affects your daily life, this study may offer a new option.
This study tests a new facial cream to reduce redness and bumps caused by rosacea, a common skin condition. The cream may help calm inflammation and improve the appearance of affected areas on the face.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This trial tests an oral medication called DF-003 for people with ROSAH syndrome who have eye inflammation (uveitis). The goal is to see if the drug is safe and tolerable. It might help reduce eye inflammation and other symptoms.
Hear when a new Erythematotelangiectatic Rosacea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.